Delivery Order SPE2DB25D9320-SPE2DB25FWEZU

The Defense Logistics Agency awarded a $773 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4560830706 XOLAIR 150 MG/ML SYRINGEML to be delivered by May 19, 2023. Xolair is the brand name for omalizumab, a prescription medicine that reduces the amount of antibody IgE in the blood. This delivery order was issued with no set-aside designation under an existing prime vendor contract vehicle held by DMS Pharmaceutical to supply...

The Defense Logistics Agency awarded a $773 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562235601 XOLAIR 150 MG/ML SYRINGEML, to be delivered by October 5, 2023. Xolair is the brand name for omalizumab, a prescription medicine that reduces the amount of antibody IgE in the blood. This delivery order was issued under an existing DLA pharmaceutical supply contract vehicle, with no set-aside designation specified. DMS Pharmaceutical...

The Defense Logistics Agency Troop Support Medical awarded a $19,342.50 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562079075 units of XOLAIR 150 MG/ML SYRINGEML to be delivered between September 5th and 26th, 2023. XOLAIR is a medication used for the treatment of asthma and chronic idiopathic urticaria. No subcontractors or set aside designations were identified. The Defense Logistics Agency supports Department of Defense health...

This is a delivery order under the DMS Pharmaceutical Group Inc.'s indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued up to $499,999,999. The order is for XOLAIR 150 MG/ML syringes, a specialty biologic medication, to be delivered to the U.S. government. The contract has a firm fixed-price pricing type and a ceiling value of $12,379.20. It does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...

The Defense Logistics Agency awarded a $9,813 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 4558369217 XOLAIR 150 MG/ML SYRINGEML. The contract has a period of performance from September 1, 2022 through September 23, 2022 and will be performed in Park Ridge, Illinois. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to provide the specified medication in support of DoD health programs. No set aside designation or subcontractors...

The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $386 firm fixed price delivery order for XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The order was awarded on October 4, 2023 under an unspecified contract vehicle and has a period of performance concluding on October 26, 2023. To be delivered to Park Ridge, Illinois, the syringes will support DLA's mission to provide pharmaceuticals and other medical supplies to the U.S. military and other government agencies. No set-aside provision...

This delivery order for $23,211 was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562584463 units of XOLAIR 150 MG/ML SYRINGES with a completion date of November 13, 2023. XOLAIR is used to treat allergic asthma and chronic idiopathic urticaria. No set-aside designation was used for this firm fixed price order to supply the pharmaceutical to the Defense Logistics Agency, the agency within the Department of Defense that...

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 mg/ml syringes. The award, valued at $11,605.50, has an ultimate completion date of April 16, 2024. This order is part of a larger indefinite delivery vehicle (IDV) contract, number 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 through 2025. Under this IDV, DMS Pharmaceutical Group...

DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $7,737 against its indefinite delivery contract with the Defense Logistics Agency to supply XOLAIR 150 MG/ML SYRINGEML. The delivery order was awarded on November 2, 2023 and has a completion date of November 27, 2023. The contract vehicle, held with the Defense Logistics Agency Troop Support Medical since December 2025, provides pharmaceutical items and medical supplies with a potential value of up to...

The Defense Logistics Agency awarded a $38,685 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562548650 units of XOLAIR 150 MG/ML SYRINGEML, to be delivered by November 9, 2023. XOLAIR is used to treat allergic asthma and chronic idiopathic urticaria. No set-aside designation was used for this award placed under an unidentified indefinite-delivery/indefinite-quantity contract vehicle. DMS Pharmaceutical Group will fulfill the order...